PTSD Treatment Beyond Talk Therapy: A 4-Stage Functional Psychiatry Approach

Jun 28

PTSD has a lifetime prevalence of about 8% in the general adult population and significantly higher in veteran populations. Only two SSRIs (sertraline and paroxetine) are FDA-approved for PTSD, with response rates of 50 to 60% and remission rates up to 30%. A functional psychiatry approach extends treatment in 4 stages: medication review and optimization, ketamine therapy for chronic PTSD when indicated, functional medicine and nutritional psychiatry workup, and integration of evidence-based trauma-focused therapy. Black Psychiatry in Utah offers this integrated approach under Christopher Black, APRN, PMHNP-BC.

What PTSD is and how common it is in 2026

Post-traumatic stress disorder (PTSD) is a trauma- and stressor-related condition defined in the DSM-5 by exposure to actual or threatened death, serious injury, or sexual violence, followed by symptom clusters that include intrusive memories, avoidance, negative changes in mood and cognition, and altered arousal and reactivity. The lifetime prevalence in the general adult population is about 8%, according to a 2022 systematic review in ScienceDirect, with significantly higher rates among certain populations.

Veterans carry a heavier load: the U.S. Department of Veterans Affairs has estimated PTSD prevalence of about 11% among veterans of the war in Afghanistan and 20% among veterans of the Iraq war. Civilian rates vary by trauma exposure: a 2024 review found that the global PTSD prevalence ranges from 2% to 26.9% depending on the population studied. Comorbidity is the norm rather than the exception; the same review found 87% of PTSD patients in one large real-world sample also met criteria for depression.

Why standard PTSD treatment leaves gaps

The FDA has approved only two medications specifically for PTSD: sertraline (Zoloft) and paroxetine (Paxil). Both are SSRIs. Across published studies, SSRIs for PTSD show response rates of 50 to 60% and full remission rates up to 30%, with high relapse rates after discontinuation. SSRIs take 4 to 8 weeks to reach full effect, which is a long time for someone in acute distress, and they can transiently increase suicidality during the early treatment window in some patients.

Evidence-based trauma-focused psychotherapies, including prolonged exposure (PE), cognitive processing therapy (CPT), and eye movement desensitization and reprocessing (EMDR), have demonstrated clear efficacy for many patients. However, these treatments require active patient engagement, time, and tolerance of distress that some patients cannot maintain at peak symptom severity. The result, often, is that the patient cannot complete the treatment that has the best evidence. A functional psychiatry approach is designed to expand the toolkit when SSRIs and talk therapy are not enough on their own.

The 4-stage functional psychiatry approach to PTSD

The 4-stage framework below organizes the major evidence-based options into a sequence that maps to clinical reality. Most patients will not need all four stages, but every patient benefits from the framework being explicit. The stages are not strictly linear; they often overlap.

4-stage functional psychiatry approach to PTSD treatment

Stage	Focus	Tools	Time Frame
1. Stabilization and assessment	Safety, sleep, baseline symptom mapping	Initial 120-min evaluation, sleep optimization, basic labs	Weeks 1-2
2. Pharmacological optimization	Right medication, right dose, right duration	SSRI/SNRI review, prazosin for nightmares, augmentation if needed	Weeks 2-12
3. Advanced pharmacotherapy when indicated	Ketamine therapy for chronic PTSD when SSRIs insufficient	IV ketamine with integration sessions	When clinically indicated
4. Trauma-focused therapy integration	Evidence-based trauma psychotherapy	Coordinated referral for PE, CPT, or EMDR	Months 2-12+

Stage 1 — Stabilization and assessment

The first goal in any PTSD treatment plan is stabilization. That means assessing safety, including suicidal ideation; addressing sleep, which is almost universally disturbed in PTSD; and mapping the baseline symptom picture clearly. The initial 120-minute consultation at Black Psychiatry covers all three, plus the medical history, prior treatment history, and the functional medicine and nutritional psychiatry markers that may be contributing.

Prazosin, an alpha-1 adrenergic antagonist, is often part of stage one because it specifically targets PTSD-related nightmares and sleep disruption. It has been used clinically for two decades for this indication. Improving sleep early creates the foundation for everything else, because PTSD symptoms worsen sharply with sleep deprivation.

Stage 2 — Pharmacological optimization

For most PTSD patients, the first-line medication choice is an SSRI, with sertraline or paroxetine FDA-approved specifically for PTSD. The optimization work is in dose and duration: most patients are under-dosed or stopped early. A full therapeutic trial means reaching the upper end of the approved dose range and staying there for at least 8 to 12 weeks before declaring the medication ineffective. SNRIs (venlafaxine) and other agents are second-line options.

Christopher Black, APRN, PMHNP-BC, reviews every PTSD patient's prior medication history at the initial appointment. Often the issue is not that SSRIs do not work for the patient, but that the patient was given an inadequate trial. Augmentation strategies (adding a second agent) are also part of stage two when monotherapy is insufficient. The decision to move to stage three is made when stages one and two have been given an honest trial and PTSD remains active and impairing.

Stage 3 — Ketamine therapy for chronic PTSD when indicated

Ketamine therapy for PTSD is one of the most actively researched advances in psychiatry. The evidence is strongest for chronic PTSD rather than acute or recently-emerged PTSD. A 2022 systematic review and meta-analysis published in Frontiers in Psychiatry concluded that ketamine was effective in improving PTSD scores for chronic conditions (risk ratio –3.66, 95% CI –7.05 to –0.27, p = 0.03), while noting it was not effective and possibly counterproductive for early or acute PTSD.

A 2025 retrospective real-world analysis of 8,136 PTSD patients (87% with comorbid depression) treated with ketamine intravenous therapy found significant reductions in PTSD and depression symptoms, with the greatest improvements occurring within the first three sessions. Black Psychiatry offers ketamine therapy for chronic PTSD as part of an integrative protocol that includes integration sessions, functional medicine evaluation, and coordination with trauma-focused psychotherapy. The treatment is not appropriate for every PTSD patient; the decision is made carefully during the evaluation.

Stage 4 — Trauma-focused therapy integration

Medication, including ketamine, does not erase trauma memories. It can reduce symptom intensity and create the neuroplastic and emotional space within which trauma-focused psychotherapy can do its work. The three evidence-based trauma-focused therapies with the strongest support are prolonged exposure (PE), cognitive processing therapy (CPT), and eye movement desensitization and reprocessing (EMDR). All three have demonstrated efficacy across military and civilian populations.

Black Psychiatry does not provide structured trauma-focused psychotherapy as its primary modality. The practice coordinates with trauma-focused therapists across Utah and prepares the patient pharmacologically and psychologically for that work. For some patients, ketamine therapy followed by EMDR or PE produces meaningfully better outcomes than either approach alone. The 4-stage framework is designed to make this integration explicit rather than leaving it to chance.

Functional medicine and nutritional psychiatry in PTSD

PTSD has well-documented effects on the autonomic nervous system, the HPA axis, inflammatory markers, and metabolic health. Chronic PTSD is associated with elevated cortisol patterns, altered gut microbiota, increased systemic inflammation, and higher rates of cardiovascular and metabolic disease. Functional psychiatry treats these downstream effects as part of the disorder, not as separate problems.

At Black Psychiatry, the workup includes functional medicine markers and nutritional psychiatry assessment from the start. This means looking at sleep architecture, dietary patterns, micronutrient status, inflammatory markers, and metabolic health alongside the more traditional psychiatric evaluation. The goal is to identify modifiable factors that are blunting the response to standard treatment, before reaching for more medications.

What to expect at your first appointment

The first appointment is 120 minutes via telehealth. Patients with PTSD often arrive with a long history of partial responses to medication, failed therapy attempts, and an understandable frustration with how the standard system has worked for them. Christopher Black, APRN, PMHNP-BC, reviews every step of that history, identifies what has actually been tried at full dose and full duration, and proposes a stage-based plan in plain language.

Booking is direct online or by phone at (801) 361-2255. Most patients receive a next-day appointment slot. The initial consultation is $850 for self-pay, with Cigna and Aetna accepted. Black Psychiatry serves all of Utah via telehealth.

Telehealth across Utah. Next-day appointments. Initial 120-minute consultation $850. Cigna and Aetna accepted.

Book a PTSD evaluation with Christopher Black, APRN, PMHNP-BC

Frequently Asked Questions

Does ketamine therapy work for PTSD?

Clinical evidence supports ketamine therapy for chronic PTSD, with a 2022 meta-analysis showing significant improvement in PTSD symptom scores (risk ratio –3.66, p = 0.03). Evidence is weaker for acute or recently-emerged PTSD. Decisions are individualized at Black Psychiatry based on the patient's specific history.

What medications are FDA-approved for PTSD?

Only two medications are FDA-approved specifically for PTSD: sertraline (Zoloft) and paroxetine (Paxil), both SSRIs. Other medications, including prazosin for nightmares and certain SNRIs, are used off-label with clinical evidence supporting their use.

Can I get PTSD treatment via telehealth in Utah?

Yes. Black Psychiatry provides telehealth-based PTSD evaluation and treatment across Utah, with next-day appointments in most cases. In-person coordination is available when treatments like ketamine therapy are part of the plan.

Does Black Psychiatry provide trauma-focused therapy directly?

Black Psychiatry coordinates with trauma-focused therapists across Utah for structured prolonged exposure (PE), cognitive processing therapy (CPT), or EMDR. The practice focuses on the psychiatric and integrative components and integrates with the patient's therapy work.

How many ketamine sessions does PTSD treatment typically require?

Real-world data from a 2025 analysis of 8,136 PTSD patients showed the greatest symptom reductions occurred within the first three sessions. A typical induction course is 6 sessions over 2 to 3 weeks, with maintenance dosing based on clinical response.

Sources Referenced

This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Reading this content does not establish a patient-provider relationship. If you are experiencing a mental health emergency, call 988 or go to your nearest emergency room. For personalized care, schedule an appointment with Christopher Black, APRN, PMHNP-BC at Black Psychiatry.

Millionaze Company